Biosimulation Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Biosimulation Market – Report Overview

Pacific Business Consulting’s “Biosimulation Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Biosimulation market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The global Biosimulation Market, valued at approximately US$ 2.7 Billion in 2022, is expected to exhibit a projected Compound Annual Growth Rate (CAGR) of over 15.0% over the next seven years. By the end of 2030, the market is anticipated to reach a valuation of US$ 15.0 Billion.

Biosimulation, also known as modeling and simulation (M&S), is becoming integral in drug development, playing a crucial role in determining drug safety and efficacy. Its applications range from drug identification and human dosing measures for diverse populations to assessing drug-drug interactions, designing clinical trials, and comparing the effectiveness of different drug candidates. Biosimulation models leverage artificial intelligence (AI) and machine learning (ML) to identify patterns and evaluate relationships among drugs, patient populations, and clinical trial parameters.

Biosimulation involves the use of computer-aided mathematical models to simulate biological processes, aiding in drug discovery and development. The drug development process is costly, and late-stage failures result in significant resource wastage. Biosimulation serves as a predictive tool, simulating biological processes to predict the outcomes of drug development.

The demand for personalized medicine, a shift from conventional medical treatment to precision medicine, coupled with a rise in cancer and chronic diseases, is a key driver for the biosimulation market. Additionally, technological advancements enabling virtual clinical trials tools contribute to market growth. The increasing number of key market players offering biosimulation software and services, along with strategic efforts to enhance product portfolios, further propels market expansion. For instance, Cadence Design Systems, Inc. entered into an agreement to acquire OpenEye Scientific Software, Inc. in July 2022, enhancing its Intelligent System Design strategy.

Biosimulation services are considered a cost-effective and time-efficient alternative, allowing researchers to explore various scenarios virtually, reducing the need for extensive experimentation. The rapid development and adoption of digital health infrastructure, including AI and ML, contribute to de-risking R&D decisions by providing actionable insights earlier in the drug development process.

Moreover, the high failure rate of clinical trials and the need to curtail the high costs of drug development are significant factors driving market growth. Clinical trials face a high failure rate, with around 50% of investigational compounds failing during the development phase, and approximately 70% of clinical trials failing in phase 2.

The increase in global R&D activities and the growing failure rate of drugs in clinical trials create a heightened demand for biosimulation software, offering lucrative opportunities in the biosimulation market forecast.

Key players in the Biosimulation segment, including Physiomics PLC, INOSIM Software GmbH, Schrödinger, Inc., Simulation Plus Inc., Cadence Design Systems, Inc., Dassault Systèmes, VeriSIM Life, Certara Inc, Genedata AG, and SimBioSys, are expected to shape the future landscape of Biosimulation technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Biosimulation market. It also delves into the analysis of present and prospective market competition within the global Biosimulation market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Biosimulation market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Biosimulation market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Biosimulation
   • Global Market Outlook: Biosimulation
2. Competitive Intelligence Analysis: Biosimulation
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Biosimulation
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Biosimulation
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Biosimulation: Ten Major Market (10MM) – Market Analysis, By Product Type
   • Software
   • Services
9. Biosimulation: Ten Major Market (10MM) – Market Analysis, By Application
   • Drug Development
   • Drug Discovery
   • Other Applications
10. Biosimulation: Ten Major Market (10MM) – Market Analysis, By End User
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutions
    • CROs
11. Biosimulation: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

12. S. Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

13. K. Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

14. Germany Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

15. France Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

16. Italy Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

17. Spain Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

18. Japan Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

19. China Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

20. Australia Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

21. India Biosimulation – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer